Zoetis (ZTS)
(Delayed Data from NYSE)
$172.37 USD
+2.81 (1.66%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $172.37 0.00 (0.00%) 5:24 PM ET
3-Hold of 5 3
C Value A Growth D Momentum C VGM
Brokerage Reports
Zoetis Inc. [ZTS]
Reports for Purchase
Showing records 181 - 200 ( 254 total )
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
On January 12, 2016, Zoetis provided an update on the company?s tax outlook for 2016 and 2017 following the European Commission?s decision to reverse certain Belgium tax benefits.
Provider: G.RESEARCH, LLC
Analyst: KEDRA K